AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference
PR Newswire
NORTH CHICAGO, Ill., May 2, 2018
NORTH CHICAGO, Ill., May 2, 2018 /PRNewswire/ -- AbbVie ABBV, a research-based global biopharmaceutical company, will participate in the 2018 Bank of America Merrill Lynch Health Care Conference on Wednesday, May 16, 2018. Richard A. Gonzalez, chairman and chief executive officer, will present at 6:20 p.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-2018-bank-of-america-merrill-lynch-health-care-conference-300640586.html
SOURCE AbbVie
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.